These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3485266

  • 1. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.
    Yong VW, Perry TL, Krisman AA.
    Neurosci Lett; 1986 Jan 02; 63(1):56-60. PubMed ID: 3485266
    [Abstract] [Full Text] [Related]

  • 2. Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Perry TL, Yong VW, Jones K, Wright JM.
    Neurosci Lett; 1986 Oct 08; 70(2):261-5. PubMed ID: 3490637
    [Abstract] [Full Text] [Related]

  • 3. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.
    Perry TL, Yong VW, Clavier RM, Jones K, Wright JM, Foulks JG, Wall RA.
    Neurosci Lett; 1985 Sep 30; 60(2):109-14. PubMed ID: 3877260
    [Abstract] [Full Text] [Related]

  • 4. Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Perry TL, Yong VW, Hansen S, Jones K, Bergeron C, Foulks JG, Wright JM.
    J Neurol Sci; 1987 Nov 30; 81(2-3):321-31. PubMed ID: 3121800
    [Abstract] [Full Text] [Related]

  • 5. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
    Ferraro TN, Golden GT, DeMattei M, Hare TA, Fariello RG.
    Neuropharmacology; 1986 Sep 30; 25(9):1071-4. PubMed ID: 2430229
    [Abstract] [Full Text] [Related]

  • 6. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
    Sharma A, Kaur P, Kumar V, Gill KD.
    Cell Mol Biol (Noisy-le-grand); 2007 Apr 15; 53(1):48-55. PubMed ID: 17519111
    [Abstract] [Full Text] [Related]

  • 8. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A.
    Neurosci Lett; 1986 Aug 29; 69(2):192-7. PubMed ID: 3489911
    [Abstract] [Full Text] [Related]

  • 9. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL, Jones K, Hansen S, Wall RA.
    Neurosci Lett; 1987 Mar 20; 75(1):65-70. PubMed ID: 3106859
    [Abstract] [Full Text] [Related]

  • 10. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice.
    Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC.
    Neurosci Lett; 1985 Jul 04; 58(1):133-7. PubMed ID: 3876523
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS, de Vries J, Hazelhoff B, Horn AS.
    J Med Chem; 1986 Mar 04; 29(3):424-7. PubMed ID: 3485197
    [Abstract] [Full Text] [Related]

  • 12. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Wall RA, Jones K.
    Neurosci Lett; 1986 Sep 12; 69(3):285-9. PubMed ID: 3489912
    [Abstract] [Full Text] [Related]

  • 13. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS.
    Brain Res; 1986 Jun 18; 376(1):117-24. PubMed ID: 3487376
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S, Fujitake J, Kuno S, Sano Y.
    Neurosci Lett; 1988 Jul 19; 90(1-2):57-62. PubMed ID: 2901058
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK, Sonsalla PK, Heikkila RE.
    J Neurochem; 1987 Mar 19; 48(3):929-34. PubMed ID: 3492590
    [Abstract] [Full Text] [Related]

  • 16. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW.
    Brain Res; 1987 Feb 10; 403(1):43-51. PubMed ID: 3493827
    [Abstract] [Full Text] [Related]

  • 17. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Janson AM, Agnati LF, Fuxe K, Cintra A, Sundstrom E, Zini I, Toffano G, Goldstein M.
    Acta Physiol Scand; 1988 Apr 10; 132(4):587-8. PubMed ID: 3265839
    [No Abstract] [Full Text] [Related]

  • 18. Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
    Janson AM, Fuxe K, Sundström E, Agnati LF, Goldstein M.
    Acta Physiol Scand; 1988 Apr 10; 132(4):589-91. PubMed ID: 3265840
    [No Abstract] [Full Text] [Related]

  • 19. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease.
    Selley ML.
    Free Radic Biol Med; 1998 Jul 15; 25(2):169-74. PubMed ID: 9667492
    [Abstract] [Full Text] [Related]

  • 20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA, Walters AS, Heikkila RE.
    Eur J Pharmacol; 1986 Jan 29; 120(3):375-7. PubMed ID: 2868908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.